STOCKHOLM, SWEDEN, – 1 December 2017. Inhalation Sciences instruments will be presented in 3 different scientific posters at the annual DDL conference in Edinburgh, UK next week (6-8…
The end of one tremendous journey, and the beginning of another. ISAB’s core technical development team met on Thursday 23 November to finesse the final touches of PreciseInhale®…
Resistance to antibiotics remains a deadly challenge. For four years the EU project FORMAMP has explored a new nanoparticle peptide treatment that could present an alternative to antibiotics….
Resistance to antibiotics remains a deadly challenge. For four years the EU project FORMAMP has explored a new nanoparticle peptide treatment that could present an alternative to antibiotics….
Spun out from ISAB in September 2017, Ziccum’s drug formulation technology air-dries drugs and vaccines into potent dry powders. It earned the interest of pharma developers looking to…
Spun out from ISAB in September 2017, Ziccum’s drug formulation technology air-dries drugs and vaccines into potent dry powders. It earned the interest of pharma developers looking to…
Our pioneering CSO Per Gerde will speak on 11 October in Lund, Sweden on CONTROLLED AEROSOL EXPOSURES, at the 6th Medicon Valley Inhalation Symposium. Medicon Valley symposia annually draw…
Astra Zeneca will release data achieved using PreciseInhale in a poster at the Association of Inhalation Toxicologists (AIT) in Copenhagen, Denmark, October 16-27. Astra Zeneca already began using…
On May 11 ISAB CSO and founder Per Gerde, and Product and Sales Manager Mikael Mikko, travelled to Hanover, Germany to install a new PreciseInhale system for Fraunhofer’s…
Inhalation Sciences and AstraZeneca have entered into a collaboration to use PreciseInhale for the evaluation of inhaled drugs. PreciseInhale is recognized as exceptionally innovative by several pioneering groups…
